Repair Biotechnologies

📍 Syracuse, United States🗓 Founded 2018👥 10 employees💰 Last funded Jul 2018
Biotechnology Research🌐 repairbiotechnologies.com
Website LinkedIn
Repair Biotechnologies is a preclinical biotechnology company focused on developing drugs for cholesterol and aging-related diseases. Our first-in-class Cholesterol Degrading Platform (CDP) technology is aimed at reversing atherosclerosis, familial hypercholesterolemias, and other conditions in which excess or modified cholesterol drives pathology.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Canada
1
Frequently asked questions
Who invested in Repair Biotechnologies?
Repair Biotechnologies has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Repair Biotechnologies last raise funding?
The most recent investment in Repair Biotechnologies recorded on gritt.io was in July 2018.
When was Repair Biotechnologies founded?
Repair Biotechnologies was founded in 2018.
What industry is Repair Biotechnologies in?
Repair Biotechnologies operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Repair Biotechnologies based?
Repair Biotechnologies is headquartered in Syracuse, United States.